Condition
Pneumococcal Diseases
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 3 (1)
Trial Status
Completed2
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07754539Phase 3RecruitingPrimary
A Study to Evaluate 20vPnC in Healthy Chinese Infants
NCT02126384Not ApplicableCompletedPrimary
Identifocation the B Cell Subsets Responsible for Anti-pneumococcal Response
NCT06970756Phase 1Not Yet RecruitingPrimary
A Phase I Clinical Study to Evaluate the Safety of PCV26 in Individuals ≥60
NCT01810861CompletedPrimary
Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in Turkey
Showing all 4 trials